Menu Close

Trending

Checkpoint inhibitors, Enhertu in spotlight as ASCO resumes in-person meetings
CSL Vifor plans UK launch after NICE backs rare disease drug Tavneos
Astellas files menopause drug fezolinetant in US, setting up Feb verdict
Frontiers Health Steering Committee spotlight: Megan Coder
Endo files for bankruptcy as it agrees opioid settlement

Deep Dive The Future of Oncology

GSKs John Fleming

Deep Dive/ Oncology/ Views & Analysis/ Views and analysis

GSK’s John Fleming on rethinking oncology from the ground up

, , , , , 0 Comment

What if we could look at cancer treatment from a completely fresh perspective? This is the philosophy GSK’s

X
GSK’s John Fleming on rethinking oncology from the ground up
https://pharmaphorum.com/views-analysis-oncology/gsks-john-fleming-on-rethinking-oncology-from-the-ground-up/
Commercialising innovative new medicines

Deep Dive/ Oncology/ Views & Analysis/ Views and analysis

Commercialising innovative new medicines

, , , , , , 0 Comment

As pharmaceutical ingenuity hits new heights, ensuring that patients gain access to innovative medicines requires a unique combination

X
Commercialising innovative new medicines
https://pharmaphorum.com/views-analysis-oncology/commercialising-innovative-new-medicines/
How to increase haematologists’ and oncologists’ confidence with new treatments

Deep Dive/ Oncology/ Views & Analysis/ Views and analysis

How to increase haematologists’ and oncologists’ confidence with new treatments

, , , , , , 0 Comment

A new whitepaper from Medscape highlights the difficulties haematologists and oncologists face in keeping up with rapid developments

X
How to increase haematologists’ and oncologists’ confidence with new treatments
https://pharmaphorum.com/views-analysis-oncology/how-to-increase-haematologists-and-oncologists-confidence-with-new-treatments/
Clinical decision support tools will help oncologists manage complexity

Deep Dive/ Oncology/ Views & Analysis/ Views and analysis

Clinical decision support tools will help oncologists manage complexity

, , , , , , 0 Comment

Making treatment decisions is a tough choice for oncologists: a therapy might save or significantly extend one patient’s

X
Clinical decision support tools will help oncologists manage complexity
https://pharmaphorum.com/views-analysis-oncology/clinical-decision-support-tools-will-help-oncologists-manage-complexity/
Solving immuno-oncology trial challenges in the COVID-19 era

Deep Dive/ Oncology/ Views & Analysis/ Views and analysis

Solving immuno-oncology trial challenges in the COVID-19 era

, , , , , , , 0 Comment

The COVID-19 pandemic has placed immense stress on healthcare provision, but the emergency may also make major advances

X
Solving immuno-oncology trial challenges in the COVID-19 era
https://pharmaphorum.com/views-analysis-oncology/solving-immuno-oncology-trial-challenges-in-the-covid-19-era/
Helping HCPs navigate the ever-evolving advanced cancer landscape

Deep Dive/ Oncology/ Views & Analysis/ Views and analysis

Helping HCPs navigate the ever-evolving advanced cancer landscape

, , , , , , , , , , 0 Comment

OPEN Health’s Christine Drewienkiewicz, Sara Black and Annie Rankin on advances in modern oncology and how pharma can

X
Helping HCPs navigate the ever-evolving advanced cancer landscape
https://pharmaphorum.com/views-analysis-oncology/helping-hcps-navigate-the-ever-evolving-advanced-cancer-landscape/
Syneos Health

Deep Dive/ Oncology/ Views & Analysis/ Views and analysis

ASCO 2020: Scientific advances & what’s impacting doctors and patients

, , , , , , 0 Comment

Despite going virtual due to the COVID-19 pandemic, Jennifer Harris, an immuno-oncology expert from Syneos Health told pharmaphorum’s

X
ASCO 2020: Scientific advances & what’s impacting doctors and patients
https://pharmaphorum.com/views-analysis-oncology/asco-2020-scientific-advances-and-the-impact-on-doctors-and-patients/

Login

CONTINUE TO SITE >
X
Close in 10 seconds